Mary Kimmel, MD, assistant professor and medical director of the Perinatal Psychiatry Inpatient Unit at the University of North Carolina, Chapel Hill, North Carolina.
American College of Obstetrics and Gynecology: “Postpartum Depression”.
National Library of Medicine: “Generalized Anxiety Disorder: Course and Risk Factors in Pregnancy,” “Detecting Prescription Drug Use Patterns During Pregnancy and Lactation with Visualization Techniques.”
Shoshana Bennett, PhD, perinatal psychologist and author of Beyond the Blues: Understanding and Treating Prenatal and Postpartum Depression and Anxiety.
JAMA Network: “Benzodiazepines and Z drugs in pregnancy are reasonably reassuring for neurodevelopment, but should we really be using them?”
Anick Berard, PhD, professor and researcher in perinatal pharmacology at the University of Montreal, Montreal, Quebec.
Berard, et al., “Association between incident exposure to benzodiazepines in early pregnancy and the risk of spontaneous abortion”, “The use of antidepressants during pregnancy and the risk of major birth defects”, “Impact of use of antidepressants, discontinuation and dosage modification on maternal depression during pregnancy. “
Bérard et al. BMJ Open. January 2017.
Harrington, et al., “Prenatal use of SSRIs and offspring with autism spectrum disorder or developmental delay”, Pediatrics, May 2014.
Berard, et al., June 24, 2019. European neuropsychopharmacology.
Markus, Miller et al., “The Other Side of the Risk Equation: Exploring the Risks of Untreated Depression and Anxiety During Pregnancy.”
Journal of Clinical Psychiatry, 2009.
The BMJ: “Specific SSRIs and Congenital Anomalies: Bayesian Analysis to Interpret New Data in the Context of Previous Reports.”